Aytu BioPharma (AYTU) News Today → DON’T buy gold until you read this (From Sasco Gold LLC) (Ad) Free AYTU Stock Alerts $3.03 0.00 (0.00%) (As of 06/10/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 23, 2024 | finance.yahoo.comAytu BioPharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024May 16, 2024 | finance.yahoo.comQ3 2024 Aytu Biopharma Inc Earnings CallMay 16, 2024 | finance.yahoo.comAytu BioPharma Inc (AYTU) Q3 2024 Earnings Call Transcript Highlights: Strategic Gains Amidst ...May 15, 2024 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma Reports Fiscal 2024 Third Quarter Operational and Financial ResultsMay 15, 2024 | markets.businessinsider.comHere's what Wall Street expects from Aytu BioPharma's earnings reportApril 17, 2024 | morningstar.comAytu BioPharma Inc 0A8MApril 2, 2024 | msn.comRedHill Biopharma looks to raise $1.25M in a direct offering of securitiesMarch 24, 2024 | morningstar.comAytu BioPharma Inc AYTUMarch 19, 2024 | seekingalpha.comSeelos drops as lead drug fails in ALS trialMarch 18, 2024 | seekingalpha.comSeelos Therapeutics files for 3.4M shares secondary offeringFebruary 25, 2024 | msn.comAytu BioPharma (AYTU) Price Target Increased by 60.00% to 8.16February 16, 2024 | finance.yahoo.comAytu BioPharma Second Quarter 2024 Earnings: Beats ExpectationsFebruary 16, 2024 | finance.yahoo.comAytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2024 Earnings Call TranscriptFebruary 15, 2024 | finance.yahoo.comQ2 2024 Aytu Biopharma Inc Earnings CallFebruary 14, 2024 | finance.yahoo.comAytu BioPharma Reports Record ADHD Revenue and Operating Income During Fiscal 2024 Second QuarterFebruary 13, 2024 | benzinga.comEarnings Preview: Aytu BioPharmaFebruary 7, 2024 | finance.yahoo.comAytu BioPharma to Report Second Quarter Fiscal 2024 Financial and Operational Results on February 14, 2024January 23, 2024 | finance.yahoo.comAytu BioPharma to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference on February 1, 2024January 16, 2024 | finance.yahoo.comWhen Will Aytu BioPharma, Inc. (NASDAQ:AYTU) Become Profitable?December 18, 2023 | benzinga.comAytu BioPharma Stock (NASDAQ:AYTU) Dividends: History, Yield and DatesNovember 30, 2023 | finance.yahoo.comAytu BioPharma to Present on the Emerging Growth Conference on December 7, 2023November 15, 2023 | finance.yahoo.comAytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2024 Earnings Call TranscriptNovember 14, 2023 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma Reports Fiscal 2024 First Quarter Financial ResultsNovember 14, 2023 | finance.yahoo.comAytu BioPharma Reports Fiscal 2024 First Quarter Financial ResultsNovember 13, 2023 | markets.businessinsider.comAytu BioPharma earnings: here's what to expectNovember 8, 2023 | finance.yahoo.comAytu BioPharma Ranked Among Fastest-Growing Companies in North America on Deloitte's Technology Fast 500(TM) for Third Consecutive YearNovember 7, 2023 | finance.yahoo.comAytu BioPharma to Report First Quarter Fiscal 2024 Financial Results on November 14, 2023October 28, 2023 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma Announces Approval of the Cotempla XR-ODT Manufacturing Site Transfer Prior Approval SupplementOctober 28, 2023 | markets.businessinsider.comAytu BioPharma: Strategic Manufacturing Transition and Financial Growth Bolster Buy RatingOctober 26, 2023 | finance.yahoo.comAytu BioPharma Announces Approval of the Cotempla XR-ODT(R) Manufacturing Site Transfer Prior Approval SupplementOctober 9, 2023 | finance.yahoo.comAytu BioPharma to Present at Lytham Partners Fall 2023 Investor Conference on October 17, 2023September 28, 2023 | finance.yahoo.comThere's No Escaping Aytu BioPharma, Inc.'s (NASDAQ:AYTU) Muted RevenuesSeptember 28, 2023 | finance.yahoo.comAytu BioPharma, Inc. (NASDAQ:AYTU) Q4 2023 Earnings Call TranscriptSeptember 27, 2023 | finance.yahoo.comAytu BioPharma Reports Record Revenues, Record Prescriptions, and Highest Adjusted EBITDA in Company History for the Fourth Quarter of Fiscal Year 2023September 26, 2023 | benzinga.comEarnings Outlook For Aytu BioPharmaSeptember 26, 2023 | markets.businessinsider.comAytu BioPharma earnings: here's what Wall Street expectsSeptember 22, 2023 | finance.yahoo.comAytu BioPharma to Report Fourth Quarter and Fiscal 2023 Financial Results on September 27, 2023September 13, 2023 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma to Present at LD Micro Main Event XVI ConferenceSeptember 13, 2023 | finance.yahoo.comAytu BioPharma to Present at LD Micro Main Event XVI ConferenceAugust 9, 2023 | msn.comMaxim Group Initiates Coverage of Aytu BioPharma (AYTU) with Buy RecommendationAugust 9, 2023 | finance.yahoo.comLoss-Making Aytu BioPharma, Inc. (NASDAQ:AYTU) Expected To Breakeven In The Medium-TermJuly 31, 2023 | finance.yahoo.comAytu BioPharma Announces Exclusive Agreement with Medomie Pharma Ltd. to Commercialize Adzenys XR-ODT(R) and Cotempla XR-ODT(R) in Israel and the Palestinian AuthorityJuly 6, 2023 | msn.comAytu BioPharma (AYTU) Price Target Increased by 71.43% to 122.40June 14, 2023 | finanznachrichten.deAytu BioPharma, Inc.: Aytu to Participate in the Maxim Group Virtual Healthcare ConferenceJune 13, 2023 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-MarketJune 13, 2023 | finance.yahoo.comAytu BioPharma Announces Closing of $4.0 Million Public Offering Priced At-the-MarketJune 9, 2023 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma Announces Pricing of $4.0 Million Public Offering Priced At-The-Market and the Appointment of a New DirectorMay 31, 2023 | msn.comHC Wainwright & Co. Reiterates Aytu BioPharma (AYTU) Buy RecommendationMay 16, 2023 | finance.yahoo.comAytu BioPharma, Inc. (NASDAQ:AYTU) Q3 2023 Earnings Call TranscriptMay 11, 2023 | finanznachrichten.deAytu BioPharma, Inc.: Aytu BioPharma Reports Third Quarter of Fiscal Year 2023 Financial Results Get Aytu BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AYTU and its competitors with MarketBeat's FREE daily newsletter. Email Address DON’T buy gold until you read this (Ad)If you're an American who understands that your money is rotting away as you read this email… Then this is for YOU. 99% of people are buying gold the wrong way. Reserve your seat here. AYTU Media Mentions By Week AYTU Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AYTU News Sentiment▼0.000.76▲Average Medical News Sentiment AYTU News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AYTU Articles This Week▼00▲AYTU Articles Average Week Get Aytu BioPharma News Delivered to You Automatically Sign up to receive the latest news and ratings for AYTU and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Eledon Pharmaceuticals News Genelux News MediciNova News Lantern Pharma News Aileron Therapeutics News Benitec Biopharma News Checkpoint Therapeutics News Viveon Health Acquisition News Rallybio News vTv Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AYTU) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | SponsoredDON’T buy gold until you read thisIf you're an American who understands that your money is rotting away as you read this email… Then this is ...Sasco Gold LLC | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored